08 November 2024
08 November 2024
The platform works in conjunction with the CARTO 3 system, enhancing the safety of ablation procedures.
The test is aimed at detecting active disease by measuring the binding activity of HPT and nTau in the brain.
New regulatory frameworks must emerge that validate and monitor these tools to harness their efficacy.
Zeiss built a GenAI app on top of Veeva Vault’s PromoMats, a regulated content app for the promotional content management lifecycle.
The test improved prediction of patient benefit from anti-PD-1 immune checkpoint inhibitors (ICIs) as a monotherapy and with chemotherapy.
The collaboration between the two will assess the potential of SolasCure’s Aurase wound gel in combat situations using non-clinical data.
The device is thin and flexible and adheres gently to the skin, providing realistic and immersive experiences.
Alcon reflected on its wholesale platform-based approach to clinical transformation during a session at the 2024 Veeva MedTech Summit.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
